A Mitocentric View of Alzheimer's Disease
- PMID: 27696116
- DOI: 10.1007/s12035-016-0117-7
A Mitocentric View of Alzheimer's Disease
Abstract
Alzheimer's disease (AD) is a neurodegenerative disease with an increasing morbidity, mortality, and economic cost. Plaques formed by amyloid beta peptide (Aβ) and neurofibrillary tangles formed by microtubule-associated protein tau are two main characters of AD. Though previous studies have focused on Aβ and tau and got some progressions on their toxicity mechanisms, no significantly effective treatments targeting the Aβ and tau have been found. However, it is worth noting that mounting evidences showed that mitochondrial dysfunction is an early event during the process of AD pathologic changes. What is more, these studies also showed an obvious association between mitochondrial dysfunction and Aβ/tau toxicity. Furthermore, both genetic and environmental factors may increase the oxidative stress and the mitochondria are also the sensitive target of ROS, which may form a vicious feedback between mitochondrial dysfunction and oxidative stress, eventually resulting in deficient energy, synaptic failure, and cell death. This article reviews the previous related studies from different aspects and concludes the critical roles of mitochondrial dysfunction in AD, suggesting a different route to AD therapy, which may guide the research and treatment direction.
Keywords: Alzheimer’s disease; Amyloid beta protein; Mitochondria; Oxidative stress; Tau proteins; Therapy.
Similar articles
-
Synaptic Mitochondria: An Early Target of Amyloid-β and Tau in Alzheimer's Disease.J Alzheimers Dis. 2021;84(4):1391-1414. doi: 10.3233/JAD-215139. J Alzheimers Dis. 2021. PMID: 34719499 Review.
-
Mechanism of Oxidative Stress and Synapse Dysfunction in the Pathogenesis of Alzheimer's Disease: Understanding the Therapeutics Strategies.Mol Neurobiol. 2016 Jan;53(1):648-661. doi: 10.1007/s12035-014-9053-6. Epub 2014 Dec 17. Mol Neurobiol. 2016. PMID: 25511446 Free PMC article. Review.
-
Interaction between NH(2)-tau fragment and Aβ in Alzheimer's disease mitochondria contributes to the synaptic deterioration.Neurobiol Aging. 2012 Apr;33(4):833.e1-25. doi: 10.1016/j.neurobiolaging.2011.08.001. Epub 2011 Sep 29. Neurobiol Aging. 2012. PMID: 21958963
-
Advanced Mitochondrial Respiration Assay for Evaluation of Mitochondrial Dysfunction in Alzheimer's Disease.Methods Mol Biol. 2016;1303:171-83. doi: 10.1007/978-1-4939-2627-5_9. Methods Mol Biol. 2016. PMID: 26235066
-
Mitochondrial Dysfunction: a Potential Therapeutic Target to Treat Alzheimer's Disease.Mol Neurobiol. 2020 Jul;57(7):3075-3088. doi: 10.1007/s12035-020-01945-y. Epub 2020 May 27. Mol Neurobiol. 2020. PMID: 32462551 Review.
Cited by
-
Amyloid Beta Oligomers Activate Death Receptors and Mitochondria-Mediated Apoptotic Pathways in Cerebral Vascular Smooth Muscle Cells; Protective Effects of Carbonic Anhydrase Inhibitors.Cells. 2023 Dec 14;12(24):2840. doi: 10.3390/cells12242840. Cells. 2023. PMID: 38132159 Free PMC article.
-
The Crosstalk Between Pathological Tau Phosphorylation and Mitochondrial Dysfunction as a Key to Understanding and Treating Alzheimer's Disease.Mol Neurobiol. 2020 Dec;57(12):5103-5120. doi: 10.1007/s12035-020-02084-0. Epub 2020 Aug 26. Mol Neurobiol. 2020. PMID: 32851560 Free PMC article. Review.
-
Small-molecule drugs development for Alzheimer's disease.Front Aging Neurosci. 2022 Nov 1;14:1019412. doi: 10.3389/fnagi.2022.1019412. eCollection 2022. Front Aging Neurosci. 2022. PMID: 36389082 Free PMC article. Review.
-
Impacts of Acute Hypoxia on Alzheimer's Disease-Like Pathologies in APPswe/PS1dE9 Mice and Their Wild Type Littermates.Front Neurosci. 2018 May 9;12:314. doi: 10.3389/fnins.2018.00314. eCollection 2018. Front Neurosci. 2018. PMID: 29867325 Free PMC article.
-
The Regulation of Cbf1 by PAS Kinase Is a Pivotal Control Point for Lipogenesis vs. Respiration in Saccharomyces cerevisiae.G3 (Bethesda). 2019 Jan 9;9(1):33-46. doi: 10.1534/g3.118.200663. G3 (Bethesda). 2019. PMID: 30381292 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical